WP
IMCR icon

Woodline Partners’s Immunocore IMCR Stock Holding History

Woodline Partners’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.1M Hold
316,762
– – 0.03% 535
2026
Q1 		$9.55M Buy
316,762
+77
+0% +$2.49K 0.04% 522
2025
Q4 		$11M Buy
316,685
+109,247
+53% +$3.86M 0.04% 435
2025
Q3 		$7.54M Sell
207,438
-39,060
-16% -$1.33M 0.04% 495
2025
Q2 		$7.74M Sell
246,498
-81,747
-25% -$2.54M 0.04% 477
2025
Q1 		$9.74M Buy
328,245
+186
+0.1% +$5.58K 0.06% 365
2024
Q4 		$9.68M Buy
328,059
+53,378
+19% +$1.69M 0.07% 350
2024
Q3 		$8.55M Buy
274,681
+643
+0.2% +$23.4K 0.07% 325
2024
Q2 		$9.29M Hold
274,038
– – 0.09% 256
2024
Q1 		$17.8M Buy
274,038
+173,710
+173% +$11.9M 0.16% 187
2023
Q4 		$6.85M Buy
+100,328
New +$5.21M 0.07% 274

Other funds holding IMCR

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Woodline Partners's IMCR Position: Q2 2026 in Review

Woodline Partners held its Immunocore (IMCR) position steady in Q2 2026 at 316,762 shares worth $10.1M. The position accounts for 0.03% of the portfolio, ranked #535.

Woodline Partners first reported a position in IMCR in Q4 2023 and has held it in 11 quarters since. The position peaked at $17.8M in Q1 2024. 135 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Woodline Partners held 316,762 shares of Immunocore worth $10.1M as of Q2 2026.
  • Woodline Partners left its Immunocore share count unchanged in Q2 2026.
  • Immunocore made up 0.03% of Woodline Partners's portfolio in Q2 2026, its #535 holding.
  • Woodline Partners first reported a position in Immunocore in Q4 2023 and has held it in 11 quarters since.
  • Woodline Partners's Immunocore position peaked at $17.8M in Q1 2024.
  • 135 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Woodline Partners's 13F filing for Q2 2026, filed 14 Aug 2026.